Trudy M. Laplaca

Trudy Laplaca practices at Lancaster General Hospital in Lancaster, Pennsylvania, part of University of Pennsylvania.

Trudy Laplaca's NPI, 1235581083, was assigned on July 5, 2016. Trudy Laplaca holds Pennsylvania license SP016272.

Trudy Laplaca's primary practice is Lancaster General Hospital, at 555 North Duke Street, Lancaster, PA 17602 in Lancaster County. The practice phone is (717) 544-5511.

Trudy Laplaca's primary practice is Lancaster General Hospital in Lancaster, Pennsylvania, part of University of Pennsylvania. The medical group on file is Lancaster Ear, Nose & Throat. Dmand AI also links Trudy Laplaca to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Trudy Laplaca practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Trudy Laplaca's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Trudy Laplaca is licensed in Pennsylvania.

CMS data shows 214 Medicare services from Trudy Laplaca across 4 procedure codes in 2024, for 213 Medicare patients. Medicare paid $21,212 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 213 Medicare patients who saw Trudy Laplaca in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Trudy Laplaca's median patient age at 58, with 56% women.

In 2024, Trudy Laplaca wrote 241 Medicare Part D claims for 163 patients. 98% of them were for generic drugs. CMS names the drug for 156 of them, across 6 drugs with 11 or more claims each, at $559 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Trudy Laplaca for performance year 2024, reported as part of a group. Trudy Laplaca accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Trudy Laplaca from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $17.